17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Under One Roof- I sometimes wonder at the number of corporations that own real property. It is oft...
Read More >
FTI Consulting (“FTI”) welcomes our clients and friends to our inaugural edition of The Activism V...
Read More >
Presented below is our summary of significant Internal Revenue Service (IRS) guidance and relevant t...
Read More >
Where does creativity fit into compliance? In more places than you think. Problem-solving, accountab...
Read More >
Many compliance officers over the years have wished for the day when what we do is at the forefront ...
Read More >
Risk allocation between parties is a key consideration in the negotiation of merger and acquisition ...
Read More >